ACURATE neo™

Aortic Valve System

Valve Design

Self-expanding & Supra-annular

ACURATE Webanimation features

Valve Measurements & Sizing

ACURATE Webanimation features

Unique Phased Top-down Deployment

ACURATE neo’s predictable, top-down deployment delivers the hemodynamic stability and precise placement needed for high procedural success and low rates of complications.
Deployment Illustration

Physician experience

"The advantage of the ACURATE neo [valve] is the very quick and intuitive implantation process, and it’s also the convincing clinical data."

Prof. Dr. Tanja Rudolph
Köln, Germany

Delivery Systems

ACURATE neo Transfemoral Delivery System

Flexible and intuitive valve delivery and positioning designed to minimize complications and improve procedural efficiency1,2

ACURATE neo Transfemoral Delivery System
ACURATE neo Transfemoral Delivery System

 

Product Specification

Access Route Transfemoral
Deployment Procedure Phased, Top-Down Deployment
Guidewire Compatibility 0.035" (0.89 mm), 14F with Expandable Introducer Set
Usable Length 109 cm
Valve Compatibility For use with all ACURATE neo Aortic Bioprosthesis (S, M, L)
Introducer Compatibility 20F (6.0 mm) with LOTUS™ Introducer Set (Small)
14F (≥ 5.5 mm) with iSLEEVE Expandable Introducer Set
Use Single Use
Sterilization Gamma Irradiation Process
Carton Size (Delivery System Only) 1,720 mm × 390 mm × 89 mm
Indications for Use The ACURATE TF Transfemoral Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aortic stenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details.

 

ACURATE neo Transapical Delivery System

The only self-expanding, supra-annular valve for transapical TAVI. Low-profile access with straightforward valve delivery and positioning minimizes complications and improves procedural efficiency3

ACURATE neo Transfemoral Delivery System
ACURATE neo Transfemoral Delivery System

 

Product Specification

Access Route Transapical
Deployment Procedure Phased, Top-Down Deployment
Guidewire Compatibility 0.035" (0.89 mm)
Usable Length 32 cm
Valve Compatibility For use with all ACURATE neo Bioprosthesis (S, M, L)
Access Sheathless
Shaft Outer Diameter 19F
Valve Housing Outer Diameter 22F
Use Single Use
Sterilization Gamma Irradiation Process
Carton Size (Delivery System Only) 1,130 mm × 390 mm × 89 mm
Indications for Use The ACURATE neo TA Transapical Delivery System with the ACURATE neo Aortic Bioprosthesis are indicated to improve valve function for symptomatic patients with severe calcific aorticstenosis (mean aortic gradient > 40 mmHg or peak jet velocity > 4.0 m/s or aortic valve area < 1.0 cm²) with high risk for conventional surgical aortic valve replacement (sAVR). See instructions for use (IFU) for details.
See a clinical case

Clinical case

A clinical case performed using the ACURATE neo Aortic Valve and Transapical Delivery System.

Prof. Dr. David Holzhey
Herzzentrum Leipzig, Germany

 
Results from case studies are not predictive of results in other cases. Results in other cases may vary. Information provided for educational purposes only.

Top